Antiviral Activity of Methylelaiophylin, an α-Glucosidase Inhibitor

Journal of Microbiology and Biotechnology

Volumn 21, Issue 3, 2011, Pages 263-266

  Lee, Doseung ^a   Woo, Jin Kyu ^a   Kim, Donghern ^b   Kim, Minyoung ^a   Cho, Somi K ^a   Kim, Jae Hoon ^a   Park, Se Pill ^a   Lee, Hyo Yeon ^a   Riu, Key Zung ^a   Lee, Dong Sun ^a  

^a Jeju National University   (South Korea)

^b National Institute of Animal Science   (South Korea)

Author keywords

Glucosidase inhibitor; Methylelaiophylin; Trafficking inhibitor

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; METHYLELAIOPHYLIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN BHK; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; IC 50; INTRACELLULAR TRANSPORT; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PROTEIN EXPRESSION; STREPTOMYCES; STREPTOMYCES MELANOSPOROFACIENS;

ALPHA-GLUCOSIDASES; ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; CRICETINAE; HN PROTEIN; INHIBITORY CONCENTRATION 50; MACROLIDES; NEWCASTLE DISEASE VIRUS; PROTEIN TRANSPORT; STREPTOMYCES;

CRICETINAE; NEWCASTLE DISEASE VIRUS; STREPTOMYCES MELANOSPOROFACIENS;

EID: 79953282646     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1011.11002     Document Type: Article

References (28)

1. Arcamone, F. M., C. Bertazzoli, M. Ghione, and T. Scotti. 1959. Melanosporin and elaiophylin, new antibiotics from Streptomyces melanosporus (sive melanosporofaciens) n. sp. G. Microbiol. 7: 207-216.
2. Asano, N. 2003. Glycosidase inhibitors: Update and perspectives on practical use. Glycobiology 13: 93-104.
3. De Melo, E. B., A. da Silveira Gomes, and I. Carvalho. 2006. α- and β-Glucosidase inhibitors: Chemical structure and biological activity. Tetrahedron 62: 10277-10302.
4. Dennis, J. W., S. Laferté, C. Waghorne, M. L. Breitman, and R. S. Kerbel. 1987. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236: 582-585.
5. Dettenhofer, M. and X. F. Yu. 2001. Characterization of the biosynthesis of human immunodeficiency virus type 1 Env from infected T-cells and the effects of glucose trimming of Env on virion infectivity. J. Biol. Chem. 276: 5985-5991.
6. Dwek, R. A. 1995. Glycobiology: Towards understanding the function of sugars. Biochem. Soc. Trans. 23: 1-25.
7. Einfeld, D. 1996. Maturation and assembly of retroviral glycoproteins. Curr. Top. Microbiol. 214: 133-176.
8. Fang, A., G. K. Wong, and A. L. Demain. 2000. Enhancement of the antifungal activity of rapamycin by the coproduced elaiophylin and nigericin. J. Antibiot. 53: 158-162.
9. Fischer, P. B., M. Collin, G. B. Karlsson, W. James, T. D. Butters, S. J. Davis, S. Gordon, R. A. Dwek, and F. M. Platt. 1995. The α-glucosidase inhibitor N- buthyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. J. Virol. 69: 5791-5797.
10. Grigoriev, P. A., R. Schlegel, and U. Grafe. 2001. Cation selective ion channels formed by macrodiolide antibiotic elaiophylin in lipid bilayer membranes. Bioelectrochemistry 54: 11-15.
11. Gruters, R. A., J. J. Neefjes, M. Tersmette, R. E. de Goede, A. Tulp, H. G. Huisman, F. Miedema, and H. L. Ploegh. 1987. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature 330: 74-77.
12. Hiebsch, R. R. and B. W. Wattenberg. 1992. Vesicle fusion in protein transport through the golgi in vitro does not involve long-lived prefusion intermediates. A reassessment of the kinetics of transport as measured by glycosylation. Biochemistry 31: 6111-6118.
13. Jacob, G. S. 1995. Glycosylation inhibitors in biology and medicine. Curr. Opin. Struct. Biol. 5: 605-611.
14. Johnson, V. A., B. D. Walker, M. A. Barlow, T. J. Paradis, T. C. Chou, and M. S. Hirsch. 1989. Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine. Antimicrob. Agents Chemother. 33: 53-57.
15. Lad, V. J. and A. K. Gupta. 2002. Inhibition of Japanese encephalitis virus maturation and transport in PS cells to cell surface by brefeldin A. Acta Virol. 46: 187-190.
16. Lee, D. S. and S. H. Lee. 2001. Genistein, a soy isoflavone, is a potent α-glucosidase inhibitor. FEBS Lett. 501: 84-86.
17. Lee, D. S., S. H. Lee, J. H. Woo, J. M. Lee, Y. B. Seu, and S. D. Hong. 1997. Antibacterial activities of methylelaiophylin. Korean J. Life Sci. 7: 180-185.
18. Muñniz, M. and H. Riezman. 2000. Intracellular transport of GPI-anchored proteins. EMBO J. 19: 10-15.
19. Muroi, M., A. Takasu, M. Yamasaki, and A. Takatsuki. 1993. Folimycin (concanamycin A), an inhibitor of V-type H(+)-ATPase, blocks cell-surface expression of virus-envelope glycoproteins. Biochem. Biophys. Res. Commun. 193: 999-1005.
20. Nakakoshi, M., N. Kimura, M. Yoshihama, and M. Uramoto. 1999. SNA-4606-1, a new member of elaiophylins with enzyme inhibition activity against testosterone 5 α-reductase. J. Antibiot. 52: 175-177.
21. Nakamura, M., Y. Kono, and A. Akatsuki. 2003. Mepanipyrim, a novel inhibitor of pharmacologically induced Golgi dispersion. Biosci. Biotechnol. Biochem. 67: 139-150.
22. Ohtsuka, S., S. Ueno, C. Yoshikumi, F. Hirose, Y. Ohmura, T. Wada, T. Fujii, and E. Takahashi. 1973. Polysaccharides having an anticarcinogenic effect and a method of producing them from species of Basidiomycetes. UK Patent 1331513, 26 September.
23. Olkkonen, V. M. and E. Ikonen. 2006. When intracellular logistics fails - genetic defects in membrane trafficking. J. Cell Sci. 119: 5031-5045.
24. Papandréou, M. J., R. Barbouche, R. Guieu, M. P. Kieny, and E. Fenouillet. 2002. The α-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step. Mol. Pharmacol. 61: 186-193.
25. Quinn, T. C. 2008. HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS 22(Suppl 3): 7-12.
26. Sagiv, Y., A. Legesse-Miller, A. Porat, and Z. Elazar. 2000. GATE-16, a membrane transport modulator, interacts with NSF and the Golgi v-SNARE GOS-28. EMBO J. 19: 1494-1504.
27. Segel, I. H. 1975. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme System, pp. 100-202. Wiley, New York.
28. Tsujii, E., M. Muroi, N. Shiragami, and A. Takatsuki. 1996. Nectrisine is a potent inhibitor of α-glucosidases, demonstrating activities similarly at enzyme and cellular levels. Biochem. Biophys. Res. Commun. 220: 459-466.